产品名称 PHA 543613 dihydrochloride
产品货号 Axon 2109 CAS [478148-58-2] MF C15H17N3O2.2HClMW 344.24 Purity: 99% Optical purity: Optically pure Soluble in water and DMSO Description Potent and selective α7 nicotinic acetylcholine receptor (nAChR) agonist, which is characterized by rapid brain penetration and high oral bioavailability; a potential treatment of cognitive deficits in schizophrenia References Certificates Categories Extra info DG Wishka et al. Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive (...). J. Med. Chem. 2006, 49(14), 4425-4436.    PR Krafft et al. PHA-543613 Preserves Blood–Brain Barrier Integrity After Intracerebral Hemorrhage in Mice. Stroke, 2013, 44(6), 1743-1747.  Certificate of Analysis Material Safety Data Sheet CNS Pain & Inflammation nAChR Unclassified Pfizer Licensed Products nAChR agonist (α7 sub-unit selective) Chemical name (R)-N-(quinuclidin-3-yl)furo[2,3-c]pyridine-5-carboxamide dihydrochloride Source information Pfizer compound; Sold for research purposes under agreement from Pfizer Inc. Parent CAS No. [478149-53-0] Order Size Unit Price Stock 10 mg €115.00 In Stock
产品价格 现货询价,电话:010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情

PHA 543613 dihydrochloride

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 2109

CAS [478148-58-2]

MF C15H17N3O2.2HCl
MW 344.24

  • Purity: 99%
  • Optical purity: Optically pure
  • Soluble in water and DMSO

PHA 543613 dihydrochloride

Description

Potent and selective α7 nicotinic acetylcholine receptor (nAChR) agonist, which is characterized by rapid brain penetration and high oral bioavailability; a potential treatment of cognitive deficits in schizophrenia
产品资料